A Johns Hopkins study shows that virtual group meetings held in partnership with early childhood learning centers offer participants valuable support and social connection.

Johns Hopkins psychiatrist Christopher Hammond seeks to address risks to adolescents that accompany legalizing the drug.

Johns Hopkins study shows a lack of training puts physicians, nurses and technicians at risk for workplace injury.

A Johns Hopkins team led by Milap Nowrangi considers the biological causes of neuropsychiatric symptoms in people with Alzheimer’s disease.

Johns Hopkins researchers find improvements in mental health, well-being and psychological functioning in study participants who use psilocybin outside of a clinical trial.

A $7.5 million gift from philanthropists Stanley and Elizabeth Star is helping Johns Hopkins scientists and clinicians better understand and treat major depression and bipolar disorders.

Johns Hopkins researchers test biomarkers to obtain a more precise diagnosis of the neurodegenerative disease.